VMD vs. CDNA, AVAH, GRAL, FTRE, PNTG, CSTL, FLGT, AUNA, TALK, and EHAB
Should you be buying Viemed Healthcare stock or one of its competitors? The main competitors of Viemed Healthcare include CareDx (CDNA), Aveanna Healthcare (AVAH), Grail (GRAL), Fortrea (FTRE), The Pennant Group (PNTG), Castle Biosciences (CSTL), Fulgent Genetics (FLGT), Auna (AUNA), Talkspace (TALK), and Enhabit (EHAB). These companies are all part of the "healthcare" industry.
Viemed Healthcare vs.
CareDx (NASDAQ:CDNA) and Viemed Healthcare (NASDAQ:VMD) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, analyst recommendations, community ranking, media sentiment, earnings, dividends and profitability.
74.2% of Viemed Healthcare shares are owned by institutional investors. 4.9% of CareDx shares are owned by company insiders. Comparatively, 20.0% of Viemed Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Viemed Healthcare has a net margin of 4.87% compared to CareDx's net margin of -45.90%. Viemed Healthcare's return on equity of 8.72% beat CareDx's return on equity.
In the previous week, CareDx had 2 more articles in the media than Viemed Healthcare. MarketBeat recorded 4 mentions for CareDx and 2 mentions for Viemed Healthcare. Viemed Healthcare's average media sentiment score of 1.71 beat CareDx's score of 1.66 indicating that Viemed Healthcare is being referred to more favorably in the news media.
CareDx received 439 more outperform votes than Viemed Healthcare when rated by MarketBeat users. Likewise, 65.87% of users gave CareDx an outperform vote while only 42.86% of users gave Viemed Healthcare an outperform vote.
CareDx has a beta of 1.95, meaning that its stock price is 95% more volatile than the S&P 500. Comparatively, Viemed Healthcare has a beta of 1.5, meaning that its stock price is 50% more volatile than the S&P 500.
CareDx presently has a consensus target price of $31.83, suggesting a potential upside of 74.62%. Given CareDx's higher possible upside, analysts clearly believe CareDx is more favorable than Viemed Healthcare.
Viemed Healthcare has lower revenue, but higher earnings than CareDx. CareDx is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks.
Summary
Viemed Healthcare beats CareDx on 10 of the 19 factors compared between the two stocks.
Get Viemed Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for VMD and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Viemed Healthcare Competitors List
Related Companies and Tools
This page (NASDAQ:VMD) was last updated on 3/27/2025 by MarketBeat.com Staff